{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:47:56Z","timestamp":1778028476552,"version":"3.51.4"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["22ZR1438000"],"award-info":[{"award-number":["22ZR1438000"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.expneurol.2025.115285","type":"journal-article","created":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T00:28:25Z","timestamp":1746750505000},"page":"115285","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Dynein-regulated brain transduction of AAV.CAP-B10 via cerebral lateral ventricle enhances hippocampal function after traumatic brain injury through Ngf gene delivery in mice"],"prefix":"10.1016","volume":"391","author":[{"given":"Jiang-Chang","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng-Hao","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng-Hui","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia-lin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Ji","family":"Weng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying-Wei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji-Yao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-Feng","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2025.115285_bb0005","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.695592","article-title":"Nerve growth factor biodelivery: a limiting step in moving toward extensive clinical application?","volume":"15","author":"Alastra","year":"2021","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.expneurol.2025.115285_bb0010","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/217258","article-title":"Neuroprotection by cocktails of dietary antioxidants under conditions of nerve growth factor deprivation","volume":"2015","author":"Amara","year":"2015","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"2","key":"10.1016\/j.expneurol.2025.115285_bb0015","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/cne.903570209","article-title":"Differential distribution of exogenous BDNF, NGF, and NT-3 in the brain corresponds to the relative abundance and distribution of high-affinity and low-affinity neurotrophin receptors","volume":"357","author":"Anderson","year":"1995","journal-title":"J. Comp. Neurol."},{"issue":"10","key":"10.1016\/j.expneurol.2025.115285_bb0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013468","article-title":"AAV-mediated gene delivery in adult GM1-gangliosidosis mice corrects lysosomal storage in CNS and improves survival","volume":"5","author":"Baek","year":"2010","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.expneurol.2025.115285_bb0025","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1086\/595830","article-title":"Worldwide epidemiology of neutralizing antibodies to adeno-associated viruses","volume":"199","author":"Calcedo","year":"2009","journal-title":"J. Infect. Dis."},{"issue":"9","key":"10.1016\/j.expneurol.2025.115285_bb0030","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1128\/CVI.05107-11","article-title":"Adeno-associated virus antibody profiles in newborns, children, and adolescents","volume":"18","author":"Calcedo","year":"2011","journal-title":"Clin. Vaccine Immunol."},{"issue":"3","key":"10.1016\/j.expneurol.2025.115285_bb0035","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/mt.2013.237","article-title":"Long-distance axonal transport of AAV9 is driven by dynein and kinesin-2 and is trafficked in a highly motile Rab7-positive compartment","volume":"22","author":"Castle","year":"2014","journal-title":"Mol. Ther."},{"issue":"7\u20138","key":"10.1016\/j.expneurol.2025.115285_bb0040","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1089\/hum.2019.367","article-title":"Postmortem analysis in a clinical trial of AAV2-NGF gene therapy for Alzheimer\u2019s disease identifies a need for improved vector delivery","volume":"31","author":"Castle","year":"2020","journal-title":"Hum. Gene Ther."},{"issue":"37","key":"10.1016\/j.expneurol.2025.115285_bb0045","doi-asserted-by":"crossref","first-page":"9928","DOI":"10.1523\/JNEUROSCI.2185-07.2007","article-title":"A single injection of an adeno-associated virus vector into nuclei with divergent connections results in widespread vector distribution in the brain and global correction of a neurogenetic disease","volume":"27","author":"Cearley","year":"2007","journal-title":"J. Neurosci."},{"issue":"8","key":"10.1016\/j.expneurol.2025.115285_bb0050","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1038\/nn.4593","article-title":"Engineered AAVs for efficient noninvasive gene delivery to the central and peripheral nervous systems","volume":"20","author":"Chan","year":"2017","journal-title":"Nat. Neurosci."},{"issue":"7","key":"10.1016\/j.expneurol.2025.115285_bb0055","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1179\/016164105X35611","article-title":"Intraventricular nerve growth factor infusion: a possible treatment for neurological deficits following hypoxic-ischemic brain injury in infants","volume":"27","author":"Chiaretti","year":"2005","journal-title":"Neurol. Res."},{"issue":"3","key":"10.1016\/j.expneurol.2025.115285_bb0060","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1179\/016164107X247948","article-title":"Intraventricular nerve growth factor infusion improves cerebral blood flow and stimulates doublecortin expression in two infants with hypoxic-ischemic brain injury","volume":"30","author":"Chiaretti","year":"2008","journal-title":"Neurol. Res."},{"issue":"3","key":"10.1016\/j.expneurol.2025.115285_bb0065","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ejpn.2007.07.016","article-title":"Nerve growth factor expression correlates with severity and outcome of traumatic brain injury in children","volume":"12","author":"Chiaretti","year":"2008","journal-title":"Eur. J. Paediatr. Neurol."},{"issue":"2","key":"10.1016\/j.expneurol.2025.115285_bb0070","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25021050","article-title":"Delivery of adeno-associated virus vectors to the central nervous system for correction of single gene disorders","volume":"25","author":"Daci","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.expneurol.2025.115285_bb0075","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nrn1104","article-title":"Viral vectors for gene delivery to the nervous system","volume":"4","author":"Davidson","year":"2003","journal-title":"Nat. Rev. Neurosci."},{"issue":"2","key":"10.1016\/j.expneurol.2025.115285_bb0080","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1006\/exnr.1997.6557","article-title":"Nerve growth factor attenuates cholinergic deficits following traumatic brain injury in rats","volume":"146","author":"Dixon","year":"1997","journal-title":"Exp. Neurol."},{"issue":"5","key":"10.1016\/j.expneurol.2025.115285_bb0085","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1159\/000017069","article-title":"Intracerebroventricular infusion of nerve growth factor in three patients with Alzheimer's disease","volume":"9","author":"Eriksdotter Jonhagen","year":"1998","journal-title":"Dement. Geriatr. Cogn. Disord."},{"issue":"11\u221212","key":"10.1016\/j.expneurol.2025.115285_bb0090","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1089\/hum.2020.301","article-title":"Intracerebroventricular administration of AAV9-PHP.B SYN1-EmGFP induces widespread transgene expression in the mouse and monkey central nervous system","volume":"32","author":"Galvan","year":"2021","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.expneurol.2025.115285_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneumeth.2023.109866","article-title":"An updated Barnes maze protocol for assessing the outcome of controlled cortical impact mouse models of traumatic brain injury","volume":"392","author":"Gee","year":"2023","journal-title":"J. Neurosci. Methods"},{"issue":"1","key":"10.1016\/j.expneurol.2025.115285_bb0100","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/s41593-021-00969-4","article-title":"AAV capsid variants with brain-wide transgene expression and decreased liver targeting after intravenous delivery in mouse and marmoset","volume":"25","author":"Goertsen","year":"2022","journal-title":"Nat. Neurosci."},{"issue":"4","key":"10.1016\/j.expneurol.2025.115285_bb0105","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/gt.2012.101","article-title":"Global CNS gene delivery and evasion of anti-AAV-neutralizing antibodies by intrathecal AAV administration in non-human primates","volume":"20","author":"Gray","year":"2013","journal-title":"Gene Ther."},{"issue":"1","key":"10.1016\/j.expneurol.2025.115285_bb0110","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1089\/hum.2017.026","article-title":"Evaluation of intrathecal routes of Administration for Adeno-Associated Viral Vectors in large animals","volume":"29","author":"Hinderer","year":"2018","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.expneurol.2025.115285_bb0115","doi-asserted-by":"crossref","DOI":"10.1038\/srep13104","article-title":"Enzyme replacement in the CSF to treat metachromatic leukodystrophy in mouse model using single intracerebroventricular injection of self-complementary AAV1 vector","volume":"5","author":"Hironaka","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.expneurol.2025.115285_bb0120","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.omtm.2018.06.004","article-title":"Toxicology study of intra-cisterna magna adeno-associated virus 9 expressing Iduronate-2-sulfatase in Rhesus macaques","volume":"10","author":"Hordeaux","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"issue":"3","key":"10.1016\/j.expneurol.2025.115285_bb0125","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.ymthe.2018.01.018","article-title":"The neurotropic properties of AAV-PHP.B are limited to C57BL\/6J mice","volume":"26","author":"Hordeaux","year":"2018","journal-title":"Mol. Ther."},{"issue":"11","key":"10.1016\/j.expneurol.2025.115285_bb0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0225206","article-title":"Delivering genes across the blood-brain barrier: LY6A, a novel cellular receptor for AAV-PHP.B capsids","volume":"14","author":"Huang","year":"2019","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.expneurol.2025.115285_bb0135","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.neuron.2019.03.020","article-title":"Therapeutic AAV gene transfer to the nervous system: a clinical reality","volume":"102","author":"Hudry","year":"2019","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.expneurol.2025.115285_bb0140","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2017.302","article-title":"Intrahippocampal injection of a lentiviral vector expressing neurogranin enhances cognitive function in 5XFAD mice","volume":"50","author":"Jeon","year":"2018","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.expneurol.2025.115285_bb0145","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/B978-0-12-800149-3.00002-0","article-title":"Clinical applications involving CNS gene transfer","volume":"87","author":"Kantor","year":"2014","journal-title":"Adv. Genet."},{"issue":"7","key":"10.1016\/j.expneurol.2025.115285_bb0150","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1073\/pnas.0810682106","article-title":"Efficient gene therapy-based method for the delivery of therapeutics to primate cortex","volume":"106","author":"Kells","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.expneurol.2025.115285_bb0155","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0014-4886(03)00258-9","article-title":"Controlled release of nerve growth factor enhances sciatic nerve regeneration","volume":"184","author":"Lee","year":"2003","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2025.115285_bb0160","series-title":"Regenerative Medicine and Brain Repair. Stem Cell Biology and Regenerative Medicine","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/978-3-031-49744-5_6","article-title":"Poly(butyl cyanoacrylate) nanoparticles deliver \u03b2-nerve growth factor to the brain after traumatic brain injury","author":"Lin","year":"2024"},{"key":"10.1016\/j.expneurol.2025.115285_bb0165","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.biomaterials.2015.08.010","article-title":"Direct hippocampal injection of pseudo lentivirus-delivered nerve growth factor gene rescues the damaged cognitive function after traumatic brain injury in the rat","volume":"69","author":"Lin","year":"2015","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.expneurol.2025.115285_bb0170","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/BF01060215","article-title":"Distribution of drugs following controlled delivery to the brain interstitium","volume":"26","author":"Mak","year":"1995","journal-title":"J. Neuro-Oncol."},{"issue":"15","key":"10.1016\/j.expneurol.2025.115285_bb0175","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1111\/bph.16056","article-title":"Acute intranasal treatment with nerve growth factor limits the onset of traumatic brain injury in young rats","volume":"180","author":"Manni","year":"2023","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2025.115285_bb0180","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.omtm.2020.10.011","article-title":"CNS transduction benefits of AAV-PHP.eB over AAV9 are dependent on administration route and mouse strain","volume":"19","author":"Mathiesen","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.expneurol.2025.115285_bb0185","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.neulet.2017.11.049","article-title":"Intravenous administration of the adeno-associated virus-PHP.B capsid fails to upregulate transduction efficiency in the marmoset brain","volume":"665","author":"Matsuzaki","year":"2018","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2025.115285_bb0190","series-title":"StatPearls","article-title":"Diffuse axonal injury","author":"Mesfin","year":"2022"},{"issue":"1","key":"10.1016\/j.expneurol.2025.115285_bb0195","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/s41598-022-27372-8","article-title":"Specific AAV2\/PHP.eB-mediated gene transduction of CA2 pyramidal cells via injection into the lateral ventricle","volume":"13","author":"Okamoto","year":"2023","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.expneurol.2025.115285_bb0200","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF02257624","article-title":"Nerve growth factor affects 11C-nicotine binding, blood flow, EEG, and verbal episodic memory in an Alzheimer patient (case report)","volume":"4","author":"Olson","year":"1992","journal-title":"J. Neural Transm. Park. Dis. Dement. Sect."},{"issue":"1","key":"10.1016\/j.expneurol.2025.115285_bb0205","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/2045-8118-8-7","article-title":"Drug transport in brain via the cerebrospinal fluid","volume":"8","author":"Pardridge","year":"2011","journal-title":"Fluids Barriers CNS"},{"issue":"5","key":"10.1016\/j.expneurol.2025.115285_bb0210","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1523\/JNEUROSCI.2676-05.2006","article-title":"Intracranial delivery of CLN2 reduces brain pathology in a mouse model of classical late infantile neuronal ceroid lipofuscinosis","volume":"26","author":"Passini","year":"2006","journal-title":"J. Neurosci."},{"issue":"5","key":"10.1016\/j.expneurol.2025.115285_bb0215","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.2744","article-title":"Barnes maze procedure for spatial learning and memory in mice","volume":"8","author":"Pitts","year":"2018","journal-title":"Bio-Protoc."},{"issue":"5","key":"10.1016\/j.expneurol.2025.115285_bb0220","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.jalz.2013.09.004","article-title":"A phase1 study of stereotactic gene delivery of AAV2-NGF for Alzheimer\u2019s disease","volume":"10","author":"Rafii","year":"2014","journal-title":"Alzheimers Dement."},{"issue":"7","key":"10.1016\/j.expneurol.2025.115285_bb0225","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1001\/jamaneurol.2018.0233","article-title":"Adeno-associated viral vector (serotype 2)-nerve growth factor for patients with Alzheimer disease: a randomized clinical trial","volume":"75","author":"Rafii","year":"2018","journal-title":"JAMA Neurol."},{"issue":"1","key":"10.1016\/j.expneurol.2025.115285_bb0230","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1186\/s12951-024-02720-0","article-title":"Brain-on-a-chip: an emerging platform for studying the nanotechnology-biology interface for neurodegenerative disorders","volume":"22","author":"Rodrigues","year":"2024","journal-title":"J. Nanobiotechnol."},{"issue":"7","key":"10.1016\/j.expneurol.2025.115285_bb0235","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1002\/dneu.22246","article-title":"The dynein inhibitor Ciliobrevin D inhibits the bidirectional transport of organelles along sensory axons and impairs NGF-mediated regulation of growth cones and axon branches","volume":"75","author":"Sainath","year":"2015","journal-title":"Dev. Neurobiol."},{"issue":"3","key":"10.1016\/j.expneurol.2025.115285_bb0240","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/gt.2012.27","article-title":"Axonal transport of adeno-associated viral vectors is serotype-dependent","volume":"20","author":"Salegio","year":"2013","journal-title":"Gene Ther."},{"issue":"5","key":"10.1016\/j.expneurol.2025.115285_bb0245","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1089\/hum.2013.005","article-title":"Strong cortical and spinal cord transduction after AAV7 and AAV9 delivery into the cerebrospinal fluid of nonhuman primates","volume":"24","author":"Samaranch","year":"2013","journal-title":"Hum. Gene Ther."},{"issue":"2","key":"10.1016\/j.expneurol.2025.115285_bb0250","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1089\/humc.2017.010","article-title":"Persistent expression of dopamine-synthesizing enzymes 15 years after gene transfer in a primate model of Parkinson\u2019s disease","volume":"28","author":"Sehara","year":"2017","journal-title":"Hum. Gene. Ther. Clin. Dev."},{"key":"10.1016\/j.expneurol.2025.115285_bb0255","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1092205","article-title":"Adherens, tight, and gap junctions in ependymal cells: a systematic review of their contribution to CSF-brain barrier","volume":"14","author":"Serra","year":"2023","journal-title":"Front. Neurol."},{"key":"10.1016\/j.expneurol.2025.115285_bb0260","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/3889300","article-title":"Brain-derived neurotrophic factor and nerve growth factor therapeutics for brain injury: the current translational challenges in preclinical and clinical research","volume":"2022","author":"Sims","year":"2022","journal-title":"Neural Plast."},{"issue":"22","key":"10.1016\/j.expneurol.2025.115285_bb0265","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1038\/sj.gt.3302549","article-title":"AAV2-mediated CLN2 gene transfer to rodent and non-human primate brain results in long-term TPP-I expression compatible with therapy for LINCL","volume":"12","author":"Sondhi","year":"2005","journal-title":"Gene Ther."},{"key":"10.1016\/j.expneurol.2025.115285_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2020.113288","article-title":"Molecular profile of the rat peri-infarct region four days after stroke: study with MANF","volume":"329","author":"Teppo","year":"2020","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.expneurol.2025.115285_bb0275","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/bja\/aem131","article-title":"Pathophysiology of traumatic brain injury","volume":"99","author":"Werner","year":"2007","journal-title":"Br. J. Anaesth."},{"issue":"5","key":"10.1016\/j.expneurol.2025.115285_bb0280","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1089\/hum.2008.022","article-title":"Treatment of late infantile neuronal ceroid lipofuscinosis by CNS administration of a serotype 2 adeno-associated virus expressing CLN2 cDNA","volume":"19","author":"Worgall","year":"2008","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.expneurol.2025.115285_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119491","article-title":"Nanomaterial-based blood-brain-barrier (BBB) crossing strategies","volume":"224","author":"Xie","year":"2019","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.expneurol.2025.115285_bb0290","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.7150\/thno.46992","article-title":"Apolipoprotein E, low-density lipoprotein receptor, and immune cells control blood-brain barrier penetration by AAV-PHP.eB in mice","volume":"11","author":"Xie","year":"2021","journal-title":"Theranostics"}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488625001499?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488625001499?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T00:27:26Z","timestamp":1749515246000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488625001499"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":58,"alternative-id":["S0014488625001499"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2025.115285","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dynein-regulated brain transduction of AAV.CAP-B10 via cerebral lateral ventricle enhances hippocampal function after traumatic brain injury through Ngf gene delivery in mice","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2025.115285","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115285"}}